Kiniksa Pharmaceuticals International (KNSA) Other Gross PP&E Adjustments: 2021-2025
Historic Other Gross PP&E Adjustments for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to -$4.9 million.
- Kiniksa Pharmaceuticals International's Other Gross PP&E Adjustments rose 67.38% to -$4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.2 million, marking a year-over-year increase of 59.46%. This contributed to the annual value of -$5.1 million for FY2024, which is 73.03% up from last year.
- Latest data reveals that Kiniksa Pharmaceuticals International reported Other Gross PP&E Adjustments of -$4.9 million as of Q3 2025, which was up 29.62% from -$7.0 million recorded in Q2 2025.
- In the past 5 years, Kiniksa Pharmaceuticals International's Other Gross PP&E Adjustments ranged from a high of $1.8 million in Q2 2022 and a low of -$19.1 million during Q4 2023.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$7.0 million (2025), whereas its average is -$8.8 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first tumbled by 186,850.00% in 2022, then surged by 90.97% in 2023.
- Kiniksa Pharmaceuticals International's Other Gross PP&E Adjustments (Quarterly) stood at -$6.3 million in 2021, then crashed by 37.57% to -$8.7 million in 2022, then plummeted by 120.10% to -$19.1 million in 2023, then spiked by 73.03% to -$5.1 million in 2024, then spiked by 67.38% to -$4.9 million in 2025.
- Its Other Gross PP&E Adjustments was -$4.9 million in Q3 2025, compared to -$7.0 million in Q2 2025 and -$6.2 million in Q1 2025.